B Singh, (1) MB ChB; Y Thandar, (2) BPharm,
MMedSc, PhD; Y Balakrishna, (3) MSc (Statistics); A Mosam, (1) MB ChB, FCDerm, MMed, PhD
P Naidoo, (1) BPharm, MB BCh,
MMedSc (Pharmacology); R Mothilal, (1) BPharm, MB BCh, MBA, DA (SA); L C Snyman, (2) BMedSci, MB ChB, MPraxMed, MMed (O&G), FCOG (SA); on behalf of the SAVE South African participating doctors
Filter, MD, FRCPC; Jon Cottreau, MD; David Moore,
MMedSc; Martin Bullock, MD, FRCPC; Weei-Yuarn Huang, PhD, MD, FRCPC; Thomas Arnason, MD, FRCPC
Q Louw, (1) PhD, MASP, BSc (Physio); J M Dizon, (2,3) PhD, MSPT, BSPT; K Grimmer, (1,2) PhD,
MMedSc, LMusA, BPt, Cert Health Economics; M McCaul, (3) MSc (Clin Epi), BTech (EMC); T Kredo, (4) 5 MMed (Clin Pharm), MB ChB, Dip HIV Man; T Young, (3,4) PhD, MMed, FCPHM, MB ChB
G L Maryke Spruyt, MB ChB, MMed (Surg); T van den Heever, MB ChB,
MMedSc (Crit Care)
E Duinslaeger, (1,3,4) MD; J H Kirby, (1,2,3) MBChB, MSc (Sports Med); J T Viljoen, (1,2,3) BSc (Physio), MPhil (Exercise Sci); P L Viviers, (1,2,3) MBChB,
MMedSc, MSc (Sports Med), FACSM
Helen Paterson (A, B) BM, DTM&H, FRANZCOG,
MMedSc * E.
CHRISTOPHER FINDLAY, BSc MB ChB
MMedSc MRCP (UK) FRCP Edin MRCGP FRCPsych DRCOG, Consultant Psychiatrist, The Brooker Centre, Halton General Hospital, Hospital Way, Runcorn, Cheshire, WA7 2DA.
An early collaborator of Barker's is Sir Peter Gluckman,
MMedSC, DSc, the chief science advisor to the prime minister of New Zealand.
Lam,
MMedSc, Occupational Therapy Department, Kowloon Hospital, Hong Kong SAR, China.
P M van Zyl, (1) MB ChB,
MMedSc (Clin Pharm), PhD; C A Gagiano, (2) MB ChB, MMed (Psych), MD; W F Mollentze, (3) MD, FCP (SA), MMed (Int), FACE, FRCP; J S Snyman, (4-5) MB ChB, MPharm Med, MD; G Joubert, (6) BA, MSc
Study's senior author, Habibul Ahsan, MD,
MMedSc, Director of the Center for Cancer Epidemiology and Prevention at the University of Chicago Medicine, said that restrictive lung defects, such as we saw in those exposed to well-water arsenic, are usually progressive and irreversible.